151 related articles for article (PubMed ID: 11960378)
21. Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells.
Benckert C; Jonas S; Cramer T; Von Marschall Z; Schäfer G; Peters M; Wagner K; Radke C; Wiedenmann B; Neuhaus P; Höcker M; Rosewicz S
Cancer Res; 2003 Mar; 63(5):1083-92. PubMed ID: 12615726
[TBL] [Abstract][Full Text] [Related]
22. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
[TBL] [Abstract][Full Text] [Related]
23. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.
Grazia Lampugnani M; Zanetti A; Corada M; Takahashi T; Balconi G; Breviario F; Orsenigo F; Cattelino A; Kemler R; Daniel TO; Dejana E
J Cell Biol; 2003 May; 161(4):793-804. PubMed ID: 12771128
[TBL] [Abstract][Full Text] [Related]
24. Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor.
Shao H; Cheng HY; Cook RG; Tweardy DJ
Cancer Res; 2003 Jul; 63(14):3923-30. PubMed ID: 12873986
[TBL] [Abstract][Full Text] [Related]
25. [Autocrine stimulation of receptor-tyrosine kinases (RTK) in human tumor cell lines in vitro: therapeutic implications].
Gaumann A; Groot M; Drexler HC; Breier G
Verh Dtsch Ges Pathol; 2003; 87():232-9. PubMed ID: 16888917
[TBL] [Abstract][Full Text] [Related]
26. Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen.
Catalano A; Romano M; Martinotti S; Procopio A
Oncogene; 2002 Apr; 21(18):2896-900. PubMed ID: 11973650
[TBL] [Abstract][Full Text] [Related]
27. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
[TBL] [Abstract][Full Text] [Related]
28. Interleukin 2 and 15 activate Stat3alpha in human T lymphocytes.
Nielsen M; Nordahl M; Svejgaard A; Odum N
Cytokine; 1998 Oct; 10(10):735-8. PubMed ID: 9811525
[TBL] [Abstract][Full Text] [Related]
29. Replication protein a 32 kDa subunit (RPA p32) binds the SH2 domain of STAT3 and regulates its transcriptional activity.
Kim J; Kim D; Chung J
Cell Biol Int; 2000; 24(7):467-73. PubMed ID: 10875894
[TBL] [Abstract][Full Text] [Related]
30. MEN2A-RET-induced cellular transformation by activation of STAT3.
Schuringa JJ; Wojtachnio K; Hagens W; Vellenga E; Buys CH; Hofstra R; Kruijer W
Oncogene; 2001 Aug; 20(38):5350-8. PubMed ID: 11536047
[TBL] [Abstract][Full Text] [Related]
31. Generation and characterization of a constitutively active Stat3 protein.
Barboza JA; Wang S; Schaefer TS
Mol Biol Rep; 2004 Mar; 31(1):13-21. PubMed ID: 15040450
[TBL] [Abstract][Full Text] [Related]
32. Correlation of chondroitin sulfate proteoglycan expression on proliferating brain capillary endothelial cells with the malignant phenotype of astroglial cells.
Schrappe M; Klier FG; Spiro RC; Waltz TA; Reisfeld RA; Gladson CL
Cancer Res; 1991 Sep; 51(18):4986-93. PubMed ID: 1893386
[TBL] [Abstract][Full Text] [Related]
33. VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance.
Lee YK; Shanafelt TD; Bone ND; Strege AK; Jelinek DF; Kay NE
Leukemia; 2005 Apr; 19(4):513-23. PubMed ID: 15703780
[TBL] [Abstract][Full Text] [Related]
34. Functional differences between Stat3alpha and Stat3beta.
Schaefer TS; Sanders LK; Park OK; Nathans D
Mol Cell Biol; 1997 Sep; 17(9):5307-16. PubMed ID: 9271408
[TBL] [Abstract][Full Text] [Related]
35. Dimer stability as a determinant of differential DNA binding activity of Stat3 isoforms.
Park OK; Schaefer LK; Wang W; Schaefer TS
J Biol Chem; 2000 Oct; 275(41):32244-9. PubMed ID: 10915797
[TBL] [Abstract][Full Text] [Related]
36. Implication of STAT3 signaling in human colonic cancer cells during intestinal trefoil factor 3 (TFF3) -- and vascular endothelial growth factor-mediated cellular invasion and tumor growth.
Rivat C; Rodrigues S; Bruyneel E; Piétu G; Robert A; Redeuilh G; Bracke M; Gespach C; Attoub S
Cancer Res; 2005 Jan; 65(1):195-202. PubMed ID: 15665295
[TBL] [Abstract][Full Text] [Related]
37. Functional significance of vascular endothelial growth factor receptor expression on human glioma cells.
Mentlein R; Forstreuter F; Mehdorn HM; Held-Feindt J
J Neurooncol; 2004; 67(1-2):9-18. PubMed ID: 15072443
[TBL] [Abstract][Full Text] [Related]
38. Variations in the levels of the JAK/STAT and ShcA proteins in human brain tumors.
Cattaneo E; Magrassi L; De-Fraja C; Conti L; Di Gennaro I; Butti G; Govoni S
Anticancer Res; 1998; 18(4A):2381-7. PubMed ID: 9703883
[TBL] [Abstract][Full Text] [Related]
39. Protein kinase Cvarepsilon mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2).
Aziz MH; Hafeez BB; Sand JM; Pierce DB; Aziz SW; Dreckschmidt NE; Verma AK
Oncogene; 2010 May; 29(21):3100-9. PubMed ID: 20228845
[TBL] [Abstract][Full Text] [Related]
40. Central role of the threonine residue within the p+1 loop of receptor tyrosine kinase in STAT3 constitutive phosphorylation in metastatic cancer cells.
Yuan ZL; Guan YJ; Wang L; Wei W; Kane AB; Chin YE
Mol Cell Biol; 2004 Nov; 24(21):9390-400. PubMed ID: 15485908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
